Agilent Technologies, Inc. (A) Jefferies Global Healthcare Conference - (Transcript)
Agilent Technologies, Inc. (NYSE:A ) Jefferies Global Healthcare Conference Call June 4, 2025 10:30 AM ET Company Participants Padraig McDonnell - CEO, President & Director Robert W. McMahon - Senior VP & CFO Conference Call Participants Tycho W.
Don't Overlook Agilent (A) International Revenue Trends While Assessing the Stock
Explore how Agilent's (A) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.
Agilent Technologies, Inc. (A) Q2 2025 Earnings Conference Call Transcript
Agilent Technologies, Inc. (NYSE:A ) Q2 2025 - Earnings Conference Call May 28, 2025 4:30 PM ET Company Participants Parmeet Ahuja – VP, IR Padraig McDonnell - President and CEO Robert W. McMahon - SVP and CFO Simon May - President of Life Sciences and Diagnostics Markets Group Angelica Riemann - President of Agilent CrossLab Group Mike Zhang - President of Applied Markets Group Conference Call Participants Patrick Donnelly - Citi Jack Meehan - Nephron Research Rachel Vatnsdal - JPMorgan Puneet Souda - Leerink Partners Vijay Kumar - Evercore ISI Tycho Peterson - Jefferies Brandon Couillard - Wells Fargo Michael Ryskin - Bank of America Dan Leonard - UBS Operator Good afternoon.
Here's What Key Metrics Tell Us About Agilent (A) Q2 Earnings
While the top- and bottom-line numbers for Agilent (A) give a sense of how the business performed in the quarter ended April 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Agilent Technologies (A) Q2 Earnings and Revenues Top Estimates
Agilent Technologies (A) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.22 per share a year ago.
Curious about Agilent (A) Q2 Performance? Explore Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended April 2025.
Agilent to Participate in Jefferies Global Healthcare Conference
SANTA CLARA, Calif--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell — along with CFO Bob McMahon — will participate in a fireside chat at the Jefferies Global Healthcare Conference at 10:30 a.m. Eastern on Wednesday, June 4, 2025, in New York City. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website. About Agilent Technologies Agilent Technologies Inc. (NYSE: A) is a global leader in anal.
Will Agilent (A) Beat Estimates Again in Its Next Earnings Report?
Agilent (A) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
The Preferred Stock IPO Market Is Frozen
This month's preferred stock IPO market is frozen, dominated by “Par Cross” and “Insider Buying” alerts, reflecting investor uncertainty due to trade tensions. The trade war and tariffs have created significant market volatility, causing companies to withdraw earnings guidance and defer investment decisions. Preferred stocks and baby bonds offer fixed payments, making them attractive during uncertain times, as they provide a “known return” amidst market unpredictability.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Fear Creates Fortunes: Grab These 7 Blue-Chip Bargains Today
Fear at extremes: Investor and consumer sentiment is near historic lows, signaling a high-probability buying opportunity, historically followed by strong 12-month gains. Economic reality check: Real-time economic indicators show GDP growth of more than 2%, despite widespread recession fears, highlighting a disconnect between sentiment and fundamentals. Inflation truth vs. hype: Real-time data shows inflation is falling, contradicting consumer fears and demonstrating that stagflation panic may be premature.
